• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic research for the development of novel aromatase inhibitors against breast cancer

Research Project

Project/Area Number 18K07018
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49020:Human pathology-related
Research InstitutionKagoshima University

Principal Investigator

Hamada Taiji  鹿児島大学, 医歯学域医学系, 助教 (30771480)

Co-Investigator(Kenkyū-buntansha) 谷本 昭英  鹿児島大学, 医歯学域医学系, 教授 (10217151)
飛田 陽  鹿児島大学, 医歯学域医学系, 准教授 (10435026)
横山 勢也  鹿児島大学, 医歯学域医学系, 助教 (20569941)
東 美智代  鹿児島大学, 医歯学域鹿児島大学病院, 准教授 (60315405)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Keywordsアロマターゼ / 乳癌 / 転写制御
Outline of Final Research Achievements

The purpose of this study is to conduct basic research on aromatase inhibitors with a new mechanism of action targeting the suppression of transcription of aromatase gene, which is different from existing aromatase inhibitors, and to solve clinical problems. We investigated the relationship between PCP4 and aromatase using aromatase activity assay, luciferase assay, and RT-qPCR analysis in cultured human breast cancer cells, and found that aromatase expression is regulated by PCP4, and the regulation is mediated by transcription from the aromatase gene. The results showed that the expression of aromatase is regulated by PCP4 and that the regulation is mediated by transcription from the aromatase gene.

Academic Significance and Societal Importance of the Research Achievements

乳癌は日本人女性で最も身近に存在する癌である。乳癌診療ガイドラインでは閉経後の乳癌治療においてアロマターゼ阻害薬を推奨しており、近年の本邦の高齢化社会と相まって、アロマターゼ阻害薬が重要な治療薬剤となっている。本研究結果から、既存のアロマターゼ阻害薬とは異なるアロマターゼ阻害の新規作用機序を明らかにしたことは学術的意義が高く、アロマターゼ阻害の新たな作用機序を提示できたことは薬剤開発につながることが期待され、本研究成果は社会的に有意義なものとなる。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (3 results)

All 2020 2018 Other

All Int'l Joint Research (1 results) Journal Article (2 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 2 results,  Open Access: 2 results)

  • [Int'l Joint Research] The Chinese University of Hong Kong(中国)

    • Related Report
      2018 Research-status Report
  • [Journal Article] PCP4/PEP19 downregulates neurite outgrowth via transcriptional regulation of Ascl1 and NeuroD1 expression in human neuroblastoma M17 cells2020

    • Author(s)
      Kitazono Ikumi、Hamada Taiji、Yoshimura Takuya、Kirishima Mari、Yokoyama Seiya、Akahane Toshiaki、Tanimoto Akihide
    • Journal Title

      Laboratory Investigation

      Volume: 100 Issue: 12 Pages: 1551-1563

    • DOI

      10.1038/s41374-020-0462-z

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells2018

    • Author(s)
      Honjo Kie、Hamada Taiji、Yoshimura Takuya、Yokoyama Seiya、Yamada Sohsuke、Tan Yan-Qin、Leung Lai K.、Nakamura Norifumi、Ohi Yasuyo、Higashi Michiyo、Tanimoto Akihide
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 51 Pages: 29619-29633

    • DOI

      10.18632/oncotarget.25651

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi